InsiderClue
Stocks · Health care · Pharmaceutical Preparations

OMEROS CORP

OMER Clue Score25
United States Fiscal year ends December CIK 0001285819 Results filed 12 Aug 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

48
Insider
Date
Role
Action
Shares
Price
Amount
David J. Borges
23 Sep 2026
VP, Finance & CAO
Sold after exercise
10,000
$20.95
$209.50K
David J. Borges
22 Sep 2026
VP, Finance & CAO
Sold after exercise
10,000
$20.95
$209.50K
Peter B Cancelmo
31 Aug 2026
VP, General Counsel
Sold after exercise
25,000
$18.54
$463.54K
Peter B Cancelmo
28 Aug 2026
VP, General Counsel
Sold after exercise
25,000
$18.65
$466.13K
Arnold C Hanish
27 Aug 2026
Director
Sold after exercise
5,000
$19.02
$95.08K
Arnold C Hanish
27 Aug 2026
Director
Sold after exercise
5,000
$18.88
$94.38K
Arnold C Hanish
26 Aug 2026
Director
Sold after exercise
5,000
$18.53
$92.63K
David J. Borges
24 Aug 2026
VP, Finance & CAO
Sold after exercise
906
$19.10
$17.30K
David J. Borges
21 Aug 2026
VP, Finance & CAO
Sold after exercise
10,000
$18.95
$189.50K
Thomas J. Cable
20 Aug 2026
Director
Sold after exercise
15,000
$18.45
$276.77K
David J. Borges
13 Aug 2026
VP, Finance & CAO
Sold after exercise
5,000
$16.95
$84.75K
Thomas J. Cable
22 May 2026
Director
Sold after exercise
7,500
$11.61
$87.04K
David J. Borges
13 Jan 2026
VP, Finance & CAO
Sold after exercise
30,000
$12.31
$369.32K
Thomas J. Cable
22 May 2023
Director
Sold after exercise
5,000
$6.53
$32.65K
Arnold C Hanish
22 May 2023
Director
Sold after exercise
5,000
$6.46
$32.30K
Gregory A MD Demopulos
17 Jun 2021
Chairman, CEO & President
Sold after exercise
36,857
$14.90
$549.17K
Gregory A MD Demopulos
15 Jun 2021
Chairman, CEO & President
Sold after exercise
36,856
$15.02
$553.58K
Gregory A MD Demopulos
20 May 2021
Chairman, CEO & President
Sold after exercise
36,856
$14.96
$551.37K
Gregory A MD Demopulos
19 May 2021
Chairman, CEO & President
Sold after exercise
36,857
$17.07
$629.15K
Gregory A MD Demopulos
8 Apr 2021
Chairman, CEO & President
Sold after exercise
35,206
$17.76
$625.26K
Gregory A MD Demopulos
7 Apr 2021
Chairman, CEO & President
Sold after exercise
37,407
$17.91
$669.96K
Michael A Jacobsen
22 Feb 2021
VP Finance and CAO
Sold after exercise
8,100
$23.28
$188.57K
Michael A Jacobsen
19 Feb 2021
VP Finance and CAO
Sold after exercise
10,000
$22.64
$226.40K
Michael A Jacobsen
10 Feb 2021
VP Finance and CAO
Sold after exercise
1,900
$22.49
$42.73K
Thomas J. Cable
13 Jan 2021
Director
Sold after exercise
5,000
$16.97
$84.85K
Thomas J. Cable
13 May 2020
Director
Sold after exercise
5,000
$14.40
$72.00K
Thomas J. Cable
3 Dec 2019
Director
Sold after exercise
10,000
$14.41
$144.15K
Marcia S. Kelbon
31 Aug 2018
VP Patent and General Counsel
Sold after exercise
5,337
$25.93
$138.38K
Marcia S. Kelbon
31 Aug 2018
VP Patent and General Counsel
Sold after exercise
2,192
$25.31
$55.47K
Marcia S. Kelbon
30 Aug 2018
VP Patent and General Counsel
Sold after exercise
35,000
$24.45
$855.75K
Marcia S. Kelbon
27 Jul 2018
VP Patent and General Counsel
Sold after exercise
5,723
$21.73
$124.36K
Marcia S. Kelbon
26 Jul 2018
VP Patent and General Counsel
Sold after exercise
35,000
$21.53
$753.69K
Marcia S. Kelbon
12 Jul 2018
VP Patent and General Counsel
Sold after exercise
4,277
$21.48
$91.89K
Michael A Jacobsen
15 May 2018
VP Finance and CAO
Sold after exercise
12,812
$24.95
$319.66K
Michael A Jacobsen
14 May 2018
VP Finance and CAO
Sold after exercise
10,980
$22.45
$246.50K
Michael A Jacobsen
3 Jan 2018
VP Finance and CAO
Sold after exercise
1,020
$22.45
$22.90K
Marcia S. Kelbon
3 Jan 2018
VP Patent and General Counsel
Sold after exercise
62,528
$21.45
$1.34M
Michael A Jacobsen
16 Jun 2017
VP Finance and CAO
Sold after exercise
12,000
$24.95
$299.40K
Michael A Jacobsen
15 Jun 2017
VP Finance and CAO
Sold after exercise
12,000
$22.45
$269.40K
Michael A Jacobsen
14 Jun 2017
VP Finance and CAO
Sold after exercise
9,350
$19.95
$186.53K
Michael A Jacobsen
13 Jun 2017
VP Finance and CAO
Sold after exercise
2,650
$19.95
$52.87K
Gregory A MD Demopulos
7 Dec 2016
Chairman, CEO & President
Sold after exercise
102,044
$10.48
$1.07M
Gregory A MD Demopulos
6 Dec 2016
Chairman, CEO & President
Sold after exercise
102,040
$10.80
$1.10M
Gregory A MD Demopulos
5 Dec 2016
Chairman, CEO & President
Sold after exercise
102,040
$10.71
$1.09M
Gregory A MD Demopulos
2 Dec 2016
Chairman, CEO & President
Sold after exercise
102,040
$11.00
$1.12M
Gregory A MD Demopulos
1 Dec 2016
Chairman, CEO & President
Sold after exercise
999
$12.32
$12.30K
Gregory A MD Demopulos
1 Dec 2016
Chairman, CEO & President
Sold after exercise
105,522
$11.56
$1.22M
Gregory A MD Demopulos
30 Nov 2016
Chairman, CEO & President
Sold after exercise
97,559
$12.21
$1.19M
Show all 70 transactions →

What was left out

Form 4 filings counted 161
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 48
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 3,710,778
Sales filed before the plan box existed 4
History held since 13 Oct 2009